Edie Weller - Concepedia

Author

Edie Weller

Also Known As

E WELLER, E Weller, E. A. Weller, E. Weller, E.A. Weller, EDIE A. WELLER, Edie A Weller, Edie A. Weller, Edie Weller, H. H. Zippel

231

Publications

16.2K

Citations

H-Index

116

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Massachusetts General Hospital Brigham and Women's Hospital Boston Children's Hospital

About

Edie Weller is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	30	1.9K
2	Health Sciences	11	12	541
3	Education	1	1	15
4	Engineering	1	1	24
5	Management	1	1	36

Edie Weller

109

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma Thomas M. Habermann, Edie Weller, Vicki A. Morrison, Journal of Clinical Oncology	2006	1.4K
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin, New England Journal of Medicine	2017	1.2K
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma Paul G. Richardson, Edie Weller, Sagar Lonial, Blood	2010	855
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Paul G. Richardson, Robert Schlossman, Edie Weller, Blood	2002	799
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression Aldo M. Roccaro, Antonio Sacco, Patricia Maiso, Journal of Clinical Investigation	2013	778
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma Paul G. Richardson, Emily Blood, Constantine S. Mitsiades, Blood	2006	520
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu Yu‐Tzu Tai, Myles Dillon, Weihua Song, Blood	2007	467
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial Philippe Armand, Arnon Nagler, Edie Weller, Journal of Clinical Oncology	2013	437
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors Andrea K. Ng, Marializa Bernardo, Edie Weller, Blood	2002	430
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma Paul G. Richardson, Susanna Jacobus, Edie Weller, New England Journal of Medicine	2022	428

Page 1